SIRT1 is required for long-term growth of human mesenchymal stem cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SIRT1 is required for long-term growth of human mesenchymal stem cells
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 90, Issue 4, Pages 389-400
Publisher
Springer Nature
Online
2011-10-26
DOI
10.1007/s00109-011-0825-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SIRT1/eNOS Axis as a Potential Target against Vascular Senescence, Dysfunction and Atherosclerosis
- (2011) Hidetaka Ota et al. Journal of Atherosclerosis and Thrombosis
- Resveratrol Protects Human Endothelium from H2O2-Induced Oxidative Stress and Senescence via SirT1 Activation
- (2011) Chung-Lan Kao et al. Journal of Atherosclerosis and Thrombosis
- Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner
- (2010) Pamela Fischer-Posovszky et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells
- (2010) Yi Zu et al. CIRCULATION RESEARCH
- SIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model
- (2010) Yu Wang et al. FEBS LETTERS
- SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
- (2010) Michelle Pacholec et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes
- (2010) Sameer Sharma et al. PHYTOTHERAPY RESEARCH
- Different Facets of Aging in Human Mesenchymal Stem Cells
- (2010) Wolfgang Wagner et al. TISSUE ENGINEERING PART B-REVIEWS
- Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo
- (2009) Jesse J Smith et al. BMC Systems Biology
- Sirtuin activators
- (2009) Francisco J Alcaín et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- BCR-ABLGene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous Leukemia
- (2009) Hongfeng Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sirolimus and Everolimus Induce Endothelial Cellular Senescence Via Sirtuin 1 Down-Regulation
- (2009) Hidetaka Ota et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recent progress in the biology and physiology of sirtuins
- (2009) Toren Finkel et al. NATURE
- A Comprehensive Review on Mesenchymal Stem Cell Growth and Senescence
- (2009) Krzysztof Książek REJUVENATION RESEARCH
- Senescence and immortality in hepatocellular carcinoma
- (2008) Mehmet Ozturk et al. CANCER LETTERS
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span
- (2008) Kevin J. Pearson et al. Cell Metabolism
- Overexpression of SPINDLIN1 induces cellular senescence, multinucleation and apoptosis
- (2008) Hongfeng Yuan et al. GENE
- PPAR accelerates cellular senescence by inducing p16INK4 expression in human diploid fibroblasts
- (2008) Q. Gan et al. JOURNAL OF CELL SCIENCE
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
- SIRT1 Acts as a Nutrient-sensitive Growth Suppressor and Its Loss Is Associated with Increased AMPK and Telomerase Activity
- (2008) Swami R. Narala et al. MOLECULAR BIOLOGY OF THE CELL
- Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases
- (2008) Mitchell D Knutson et al. NUTRITION REVIEWS
- SIRT1 Overexpression Antagonizes Cellular Senescence with Activated ERK/S6k1 Signaling in Human Diploid Fibroblasts
- (2008) Jing Huang et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started